Palo Alto, California, United StatesFounded 202128+ employeesPrivate
$26M raisedSeries A· last: series a (May 2024)· 2 rounds
Backed by(19 investors)
Valar Labs makes AI to interpret solid tumors and deliver insights, so physicians and patients can make informed treatment decisions. Their AI algorithms analyze digitized pathology slides to assess spatial features, and they design transparent systems grounded in underlying biology so physicians can trust the results.
